US Equine Healthcare Market: Will 2026 Be the Year of Regenerative Breakthroughs?
As of January 2026, the US equine healthcare market is identifying as a high-value sector within North American veterinary medicine, with the market projected to reach a valuation of $820 million this year. The 2026 landscape is defined by a massive surge in the adoption of regenerative medicine, such as stem cell and platelet-rich plasma (PRP) therapies, particularly for high-performance...
ไลค์
1
0 ความคิดเห็น 0 แชร์ 574 ยอดวิว 0 รีวิว